Institutional investors purchased a net $1.2 million shares of CDXS during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 24.53% of shares outstanding that institutional investors hold is actually below the Chemicals: Specialty industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEDICAL STRATEGY GMBH Bought 141.7 Thousand shares of Codexis Inc